Data / Form D filings / Tetra Bio-Pharma Inc.
Tetra Bio-Pharma Inc.: Form D filing
Tetra Bio-Pharma Inc., a pharmaceuticals company in Orleans, Ontario, Canada (Federal Level), filed a Form D with the SEC in 2020. The latest, on June 12, 2020, reports $371,020 sold of a $371,020 offering to 1 investor.
Find out what Tetra Bio-Pharma Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2316 ST. JOSEPH BLVD., Orleans, Ontario, Canada (Federal Level), K1C 1
- Phone
- (438) 899-7575
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Canada (Federal Level)
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1814888
The full lists. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Form D filings: 44,302 rows, $523.02, or the new rows each week for $92.05 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 12, 2020 | New notice | $371,020 | $371,020 | $0 | 1 | May 22, 2020 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| BILL CHELIAK | Director | |
| SABINO DI PAOLA | Executive Officer | |
| CARL MERTON | Director | |
| GUY CHAMBERLAND | Executive Officer | |
| GREGORY DROHAN | Director |
Every Form D from the week of Jun 8, 2020 · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Tetra Bio-Pharma Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.